Why is Shenzhen Weiguang Biological Products Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 6.63% and Operating profit at 9.65% over the last 5 years
2
Negative results in Mar 25
- INTEREST(HY) At CNY 11.92 MM has Grown at 17.94%
- INTEREST COVERAGE RATIO(Q) Lowest at 1,172.3
- OPERATING PROFIT MARGIN(Q) Lowest at 24.43 %
3
Below par performance in long term as well as near term
- Along with generating -6.56% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shenzhen Weiguang Biological Products Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shenzhen Weiguang Biological Products Co., Ltd.
-12.79%
-0.20
23.81%
China Shanghai Composite
14.77%
1.01
15.10%
Quality key factors
Factor
Value
Sales Growth (5y)
6.63%
EBIT Growth (5y)
9.65%
EBIT to Interest (avg)
51.08
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.39
Tax Ratio
14.79%
Dividend Payout Ratio
17.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.71%
ROE (avg)
10.33%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.65
EV to EBIT
21.01
EV to EBITDA
14.61
EV to Capital Employed
2.34
EV to Sales
5.52
PEG Ratio
1.27
Dividend Yield
0.75%
ROCE (Latest)
11.13%
ROE (Latest)
11.63%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 1.03% (YoY
-15What is not working for the Company
INTEREST(HY)
At CNY 11.92 MM has Grown at 17.94%
INTEREST COVERAGE RATIO(Q)
Lowest at 1,172.3
OPERATING PROFIT MARGIN(Q)
Lowest at 24.43 %
DEBT-EQUITY RATIO
(HY)
Highest at 16.39 %
NET SALES(Q)
Lowest at CNY 222.97 MM
OPERATING PROFIT(Q)
Lowest at CNY 54.47 MM
PRE-TAX PROFIT(Q)
Lowest at CNY 53.03 MM
NET PROFIT(Q)
Lowest at CNY 43.77 MM
EPS(Q)
Lowest at CNY 0.19
Here's what is working for Shenzhen Weiguang Biological Products Co., Ltd.
Raw Material Cost
Fallen by 1.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shenzhen Weiguang Biological Products Co., Ltd.
Interest
At CNY 11.92 MM has Grown at 17.94%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 1,172.3
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit Margin
Lowest at 24.43 % and Fallen
In each period in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Sales
Lowest at CNY 222.97 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 54.47 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Pre-Tax Profit
Lowest at CNY 53.03 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 43.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.19
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Debt-Equity Ratio
Highest at 16.39 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






